In short, dermatologists play a central role in diagnosing and treating basal cell skin cancer through specialized techniques like Mohs micrographic surgery.
- Expert diagnosis – Dermatologists use advanced diagnostic tools to accurately identify basal cell carcinoma.
- Mohs surgery – This precise surgical technique removes cancerous tissue while preserving healthy skin.
- Ongoing monitoring – Regular follow-up care helps detect recurrence and manage long-term skin health.
Treatment for basal cell skin cancer requires specialized medical expertise that dermatologists are uniquely qualified to provide. Basal cell carcinoma (BCC) is the most common form of skin cancer, with approximately 3.6 million cases diagnosed annually in the United States, according to the Skin Cancer Foundation. While this type of cancer rarely metastasizes, it can cause significant tissue damage if left untreated, making early detection and proper treatment essential.
Understanding the comprehensive role dermatologists play in treating BCC can help patients make informed decisions about their care and achieve the best possible outcomes.
What Is Basal Cell Skin Cancer?
Basal cell carcinoma develops in the basal cells, which are located in the deepest layer of the epidermis. These cells continuously divide to form new skin cells that gradually move toward the surface. When DNA damage occurs in these cells, often from ultraviolet (UV) radiation exposure, they can begin to multiply uncontrollably, forming a cancerous tumor.
BCC typically appears on sun-exposed areas of the body, including the face, neck, arms, and hands. The lesions may present as pearly or waxy bumps, flat flesh-colored or brown scar-like lesions, or bleeding or scabbing sores that heal and return.
Several risk factors increase the likelihood of developing basal cell skin cancer. Fair skin, a history of sunburns, chronic sun exposure, radiation therapy, and a weakened immune system all contribute to elevated risk. Additionally, a study published in JAMA Dermatology revealed that individuals with a personal history of one BCC have a 44% chance of developing another within three years, emphasizing the importance of ongoing dermatological surveillance.
How Do Dermatologists Diagnose Basal Cell Skin Cancer?
Dermatologists employ a systematic approach to diagnose basal cell skin cancer, beginning with a comprehensive skin examination.
During this visual inspection, the physician examines the entire body for suspicious lesions, paying particular attention to areas with high sun exposure. Dermatologists are trained to recognize the subtle characteristics that distinguish BCC from benign skin conditions.
Skin Biopsy
When a suspicious lesion is identified, dermatologists perform a skin biopsy to confirm the diagnosis. This procedure involves removing a small sample of tissue for microscopic examination by a pathologist.
Several biopsy techniques may be used depending on the lesion’s size, location, and characteristics. A shave biopsy removes the top layers of skin, while a punch biopsy uses a circular blade to remove a deeper sample. An excisional biopsy removes the entire lesion along with a margin of surrounding tissue.
Pathology and BCC Subtypes
The pathology report provides critical information about the cancer, including the specific subtype of BCC. The major subtypes include nodular, superficial, infiltrative, and morpheaform, each with different growth patterns and treatment implications.
Dermatologists use this information to develop an individualized treatment plan that addresses the unique characteristics of each patient’s cancer.
Advanced Diagnostic Tools
Advanced diagnostic tools enhance dermatologists’ ability to detect and evaluate basal cell skin cancer. Dermoscopy, a non-invasive technique that uses magnification and specialized lighting, allows physicians to examine skin structures not visible to the naked eye.
Reflectance confocal microscopy provides even greater detail by creating high-resolution images of cellular structures in real time, potentially reducing the need for biopsy in some cases.
What Treatment Options Do Dermatologists Offer for Basal Cell Skin Cancer?
Dermatologists provide a range of treatment options for basal cell skin cancer, tailored to the tumor’s size, location, subtype, and the patient’s overall health. The primary goal of treatment for basal cell skin cancer is complete removal of cancerous tissue while preserving as much healthy tissue as possible and maintaining optimal cosmetic outcomes.
Mohs Micrographic Surgery
Mohs micrographic surgery represents the gold standard for treating high-risk basal cell carcinomas, particularly those located on cosmetically sensitive areas like the face. This specialized technique, performed by fellowship-trained Mohs surgeons, offers the highest cure rate of any treatment method, approaching 99% for primary BCCs and 94% for recurrent tumors.
The procedure involves removing the visible tumor along with a thin margin of surrounding tissue. The surgeon then examines 100% of the surgical margin under a microscope while the patient waits. If cancer cells remain, additional tissue is removed from only the affected area, sparing healthy tissue. This process continues until no cancer cells are detected, ensuring complete removal while minimizing the size of the wound.
Excisional Surgery
Standard excisional surgery involves removing the entire tumor along with a predetermined margin of normal-appearing skin. The tissue is then sent to a pathology laboratory for examination. This approach works well for low-risk BCCs in areas where tissue preservation is less critical. Dermatologists typically recommend a 4-millimeter margin for low-risk tumors and wider margins for high-risk lesions.
The primary limitation of excisional surgery compared to Mohs technique is that only a small percentage of the surgical margin undergoes microscopic examination. This means small extensions of cancer cells may go undetected, potentially leading to recurrence.
Electrodesiccation and Curettage
For small, superficial basal cell carcinomas in low-risk locations, dermatologists may recommend electrodesiccation and curettage (ED&C). This technique involves scraping away the tumor with a curette, a spoon-shaped instrument, followed by cauterization of the base with an electric needle. The process is typically repeated two or three times to ensure complete removal.
ED&C offers the advantages of being quick, cost-effective, and suitable for office-based treatment. However, this method has higher recurrence rates than surgical excision or Mohs surgery and may produce less favorable cosmetic results due to scarring.
Topical Medications
Dermatologists may prescribe topical medications for superficial basal cell carcinomas that are small and located in low-risk areas.
Imiquimod (Aldara) is an immune response modifier that stimulates the body’s natural defenses to fight cancer cells. Patients apply the cream to the affected area several times per week for several weeks.
Fluorouracil (5-FU), marketed under brand names like Efudex and Fluoroplex, is a chemotherapy cream that destroys rapidly dividing cancer cells. Treatment typically continues for several weeks and may cause significant inflammation and crusting before healing occurs.
Radiation Therapy
Radiation therapy serves as an alternative treatment for basal cell skin cancer when surgery is not feasible due to the tumor’s location, the patient’s health status, or patient preference. Dermatologists may refer patients to radiation oncologists who deliver targeted doses of radiation to destroy cancer cells while minimizing damage to surrounding tissue.
This approach typically requires multiple treatment sessions over several weeks. While effective for tumor control, radiation therapy carries risks of long-term skin changes and a small possibility of inducing secondary cancers years later.
Expert Treatment for Basal Cell Skin Cancer in Miami, FL
If you have been diagnosed with basal cell skin cancer or have a concerning skin lesion, specialized dermatological care can make a significant difference in your treatment outcomes. At The Dermatology and Skin Cancer Center in Miami, FL, Dr. Giuffrida specializes in Mohs micrographic surgery for the treatment of high-risk skin cancers. With expertise in both cancer removal and reconstructive techniques, Dr. Giuffrida provides comprehensive care that prioritizes both cure and cosmetic results.
Contact The Dermatology and Skin Cancer Center at (305) 461-2000 or use our appointment form to schedule a consultation and receive personalized care from a dedicated skin cancer expert.
